Medications for Crohn Disease

151 results
Pfizer Laboratories Div Pfizer Inc
Usage: ABRILADA is indicated for treating moderately to severely active rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, chronic plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis in adults and pediatric patients 2 years and older.
Nelco Laboratories, Inc.
Usage: Allergenic extracts are indicated for diagnostic testing and treatment of allergic diseases. They serve as hyposensitization or immunotherapy when allergen avoidance is insufficient and may be used alongside medications like antihistamines and corticosteroids, targeting specific allergens based on patient history and exposure.
Golden State Medical Supply, Inc.
Usage: Adalimumab-fkjp is indicated for various conditions, including rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, plaque psoriasis, and hidradenitis suppurativa. It reduces symptoms, inhibits structural damage progression, and improves physical function in affected patients.
Optum Health Solutions (Ireland) Limited
Usage: AMJEVITA is indicated for treating moderately to severely active rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, chronic plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis. It can be used alone or with other therapies.
Amgen Inc
Usage: AMJEVITA is indicated for treating moderately to severely active rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, chronic plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis in adults and pediatric patients. It can be used alone or with DMARDs.

Avsola (infliximab-axxq)

(infliximab-axxq)
Amgen Inc
Usage: AVSOLA is indicated for treating moderately to severely active Crohn's disease and ulcerative colitis in adults and pediatric patients (6+ years), along with rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and chronic severe plaque psoriasis in adults, particularly for those who have inadequate responses to conventional therapies.
Wockhardt USA, LLC
Usage: This drug is indicated for various conditions, including endocrine disorders (e.g., adrenal insufficiency), rheumatic disorders (e.g., arthritis), collagen diseases, dermatologic diseases, severe allergic reactions, ophthalmic inflammation, respiratory diseases, hematologic disorders, neoplastic diseases, edematous states, gastrointestinal diseases, and special cases like tuberculous meningitis and trichinosis.

Beta 1 kit (betamethasone sodium phosphate, betamethasone acetate)

(Betamethasone Sodium Phosphate, Betamethasone Acetate)
Oaklock, LLC
Usage: Betamethasone Sodium Phosphate and Betamethasone Acetate Injectable Suspension is indicated for severe allergic conditions, dermatologic diseases, endocrine disorders, gastrointestinal diseases, hematologic disorders, neurologic conditions, and various inflammatory diseases. It serves as adjunctive therapy for specific acute episodes and can be used intramuscularly, intra-articularly, or intralesionally.

Betaloan suik (betamethasone sodium phosphate and betamethasone acetate)

(Betamethasone Sodium Phosphate and Betamethasone Acetate)
Asclemed USA, Inc.
Usage: Betamethasone Sodium Phosphate and Betamethasone Acetate Injectable Suspension is indicated for severe allergic conditions, dermatologic and endocrine disorders, gastrointestinal diseases, hematologic disorders, palliative care in neoplastic diseases, nervous system issues, ocular inflammatory conditions, renal diseases, respiratory diseases, and rheumatic disorders. It is used intramuscularly, intra-articularly, or intralesionally.
Major Pharmaceuticals
Usage: Budesonide delayed-release capsules are indicated for treating mild to moderate active Crohn's disease in patients aged 8 and older and for maintaining clinical remission of the disease in adults for up to 3 months, specifically targeting the ileum and/or ascending colon.
  • ...